These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31644398)

  • 1. The lock-in loophole: Using mixed methods to explain patient circumvention of a Medicaid opioid restriction program.
    Roberts AW; Skinner AC; Lauffenburger JC; Galt KA
    Subst Abus; 2020; 41(4):510-518. PubMed ID: 31644398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled Substance Lock-In Programs: Examining An Unintended Consequence Of A Prescription Drug Abuse Policy.
    Roberts AW; Farley JF; Holmes GM; Oramasionwu CU; Ringwalt C; Sleath B; Skinner AC
    Health Aff (Millwood); 2016 Oct; 35(10):1884-1892. PubMed ID: 27702963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating short- and long-term impacts of a Medicaid "lock-in" program on opioid and benzodiazepine prescriptions dispensed to beneficiaries.
    Naumann RB; Marshall SW; Lund JL; Gottfredson NC; Ringwalt CL; Skinner AC
    Drug Alcohol Depend; 2018 Jan; 182():112-119. PubMed ID: 29150151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trajectories of dispensed prescription opioids among beneficiaries enrolled in a Medicaid controlled substance "lock-in" program.
    Naumann RB; Marshall SW; Gottfredson NC; Lund JL; Ringwalt CL; Skinner AC
    Pharmacoepidemiol Drug Saf; 2019 Jan; 28(1):16-24. PubMed ID: 29700904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient Outcomes in a Medicaid Managed Care Lock-In Program.
    Dreyer TR; Michalski T; Williams BC
    J Manag Care Spec Pharm; 2015 Nov; 21(11):1006-12. PubMed ID: 26521112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using prescription monitoring program data to characterize out-of-pocket payments for opioid prescriptions in a state Medicaid program.
    Hartung DM; Ahmed SM; Middleton L; Van Otterloo J; Zhang K; Keast S; Kim H; Johnston K; Deyo RA
    Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1053-1060. PubMed ID: 28722211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing Opioid Misuse: Evaluation of a Medicaid Controlled Substance Lock-In Program.
    Skinner AC; Ringwalt C; Naumann RB; Roberts AW; Moss LA; Sachdeva N; Weaver MA; Farley J
    J Pain; 2016 Nov; 17(11):1150-1155. PubMed ID: 27497767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the present state and potential of Medicaid controlled substance lock-in programs.
    Roberts AW; Skinner AC
    J Manag Care Spec Pharm; 2014 May; 20(5):439-46c. PubMed ID: 24761815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of trends in opioid dispensing patterns between Medicaid pharmacy claims and prescription drug monitoring program data.
    El Ibrahimi S; Hallvik S; Johnston K; Leichtling G; Choo E; Hartung DM
    Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1168-1174. PubMed ID: 32939909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a Medicaid Lock-in Program: Increased Use of Opioid Use Disorder Treatment but No Impact on Opioid Overdose Risk.
    Naumann RB; Roberts AW; Marshall SW; Skinner AC
    Med Care; 2019 Mar; 57(3):213-217. PubMed ID: 30629016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incremental Effect of the Addition of Prescriber Restrictions on a State Medicaid's Pharmacy-Only Patient Review and Restriction Program.
    Keast SL; Pham T; Teel A; Nesser NJ
    J Manag Care Spec Pharm; 2017 Aug; 23(8):875-883. PubMed ID: 28737989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. North Carolina Medicaid recipient management lock-in program: the pharmacist's perspective.
    Werth SR; Sachdeva N; Roberts AW; Garrettson M; Ringwalt C; Moss LA; Pikoulas T; Skinner AC
    J Manag Care Spec Pharm; 2014 Nov; 20(11):1122-9. PubMed ID: 25351973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impacts of a Medicaid "lock-in" program on opioid use disorder treatment and services and naloxone dispensing.
    Naumann RB; Austin AE; Wang L; Roberts AW
    Drug Alcohol Depend; 2022 Apr; 233():109385. PubMed ID: 35276627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacist and physician satisfaction and rates of switching to preferred medications associated with an instant prior authorization program for proton pump inhibitors in the North Carolina Medicaid program.
    Jacobson Vann JC; Christofferson S; Humble CG; Wegner SE; Feaganes JR; Trygstad TK
    J Manag Care Pharm; 2010 May; 16(4):250-63. PubMed ID: 20433216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid prescribing restrictions and opioid use among the Louisiana Medicaid population.
    Callison K; Karletsos D; Walker B
    Int J Drug Policy; 2022 Sep; 107():103770. PubMed ID: 35780564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion to Persistent or High-Risk Opioid Use After a New Prescription From the Emergency Department: Evidence From Washington Medicaid Beneficiaries.
    Meisel ZF; Lupulescu-Mann N; Charlesworth CJ; Kim H; Sun BC
    Ann Emerg Med; 2019 Nov; 74(5):611-621. PubMed ID: 31229392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of an opioid management initiative by a state Medicaid program.
    Garcia MM; Angelini MC; Thomas T; Lenz K; Jeffrey P
    J Manag Care Spec Pharm; 2014 May; 20(5):447-54. PubMed ID: 24761816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors and Outcomes of Opioid Users with and Without Concurrent Benzodiazepine Use in the North Carolina Medicaid Population.
    Hung A; Bush C; Greiner M; Campbell H; Hammill B; Maciejewski ML; McKethan A
    J Manag Care Spec Pharm; 2020 Feb; 26(2):169-175. PubMed ID: 32011957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of an office-based addiction treatment model for Medicaid enrollees: A mixed methods study.
    Treitler P; Enich M; Bowden C; Mahone A; Lloyd J; Crystal S
    J Subst Use Addict Treat; 2024 Jan; 156():209212. PubMed ID: 37935350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.